Contribution of the Respiratory Syncytial Virus G Glycoprotein and Its Secreted and Membrane-Bound Forms to Virus Replication in Vitro and in Vivo
|
journal
|
October 2001 |
Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming
|
journal
|
December 2009 |
Time and Out-of-Pocket Costs Associated with Respiratory Syncytial Virus Hospitalization of Infants
|
journal
|
March 2003 |
Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater In Vivo Protection than the Murine Precursor of Palivizumab
|
journal
|
May 2017 |
Overview of the CCP 4 suite and current developments
|
journal
|
March 2011 |
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
|
journal
|
November 2011 |
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning
|
journal
|
January 2008 |
Cell Biology of Virus Entry
|
journal
|
June 2000 |
Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation
|
journal
|
February 2018 |
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
|
journal
|
April 2013 |
Respiratory Syncytial Virus with the Fusion Protein as Its only Viral Glycoprotein Is Less Dependent on Cellular Glycosaminoglycans for Attachment than Complete Virus
|
journal
|
March 2002 |
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
|
journal
|
October 2013 |
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
|
journal
|
June 1998 |
Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
|
journal
|
January 2013 |
Ongoing developments in RSV prophylaxis: a clinician’s analysis
|
journal
|
June 2017 |
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
|
journal
|
April 2017 |
Effect of Proteolytic Processing at Two Distinct Sites on Shape and Aggregation of an Anchorless Fusion Protein of Human Respiratory Syncytial Virus and Fate of the Intervening Segment
|
journal
|
July 2002 |
Specific Single or Double Proline Substitutions in the “Spring-loaded” Coiled-Coil Region of the Influenza Hemagglutinin Impair or Abolish Membrane Fusion Activity
|
journal
|
June 1998 |
Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor
|
journal
|
August 2017 |
Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein
|
journal
|
October 2015 |
Molecular mechanism of respiratory syncytial virus fusion inhibitors
|
journal
|
December 2015 |
Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein
|
journal
|
July 2015 |
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
|
journal
|
August 2013 |
Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV
|
journal
|
August 2016 |
Structural basis of respiratory syncytial virus neutralization by motavizumab
|
journal
|
January 2010 |
Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein
|
journal
|
November 2017 |
Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention
|
journal
|
February 2012 |
Inference of Macromolecular Assemblies from Crystalline State
|
journal
|
September 2007 |
Soluble Respiratory Syncytial Virus Fusion Protein in the Fully Cleaved, Pretriggered State Is Triggered by Exposure to Low-Molarity Buffer
|
journal
|
February 2011 |
Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment
|
journal
|
November 2016 |
Respiratory Syncytial Virus-Associated Mortality in Hospitalized Infants and Young Children
|
journal
|
December 2014 |
Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors
|
journal
|
December 2016 |
Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion
|
journal
|
August 2001 |
IMGT(R), the international ImMunoGeneTics information system(R)
|
journal
|
January 2009 |
iMOSFLM : a new graphical interface for diffraction-image processing with MOSFLM
|
journal
|
March 2011 |
Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein
|
journal
|
October 2016 |
The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates
|
journal
|
October 2018 |
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
|
journal
|
September 2017 |
Blocking Intercellular Adhesion Molecule-1 on Human Epithelial Cells Decreases Respiratory Syncytial Virus Infection
|
journal
|
January 2001 |
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
|
journal
|
February 2017 |
Beyond Receptor Expression: The Influence of Receptor Conformation, Density, and Affinity in HIV-1 Infection
|
journal
|
October 2000 |
EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression
|
journal
|
May 2016 |
Recombinant Vesicular Stomatitis Virus Expressing Respiratory Syncytial Virus (RSV) Glycoproteins: RSV Fusion Protein Can Mediate Infection and Cell Fusion
|
journal
|
February 1999 |
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|
journal
|
August 2017 |
Identification of nucleolin as a cellular receptor for human respiratory syncytial virus
|
journal
|
August 2011 |
Structural characterization of the human respiratory syncytial virus fusion protein core
|
journal
|
December 2000 |
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
Architecture of respiratory syncytial virus revealed by electron cryotomography
|
journal
|
June 2013 |
Elevated temperature triggers human respiratory syncytial virus F protein six-helix bundle formation
|
journal
|
January 2010 |
Pre-fusion structure of a human coronavirus spike protein
|
journal
|
March 2016 |
Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein
|
journal
|
November 2017 |
Proteolytic Activation of Respiratory Syncytial Virus Fusion Protein: CLEAVAGE AT TWO FURIN CONSENSUS SEQUENCES
|
journal
|
June 2001 |
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
|
journal
|
October 2015 |
Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective
|
journal
|
January 2014 |
Heptad-Repeat Regions of Respiratory Syncytial Virus F 1 Protein Form a Six-Membered Coiled-Coil Complex
|
journal
|
September 2000 |
Phaser crystallographic software
|
journal
|
July 2007 |
A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism
|
journal
|
September 2015 |
Circulation of human coronaviruses OC43 and 229E in Córdoba, Argentina
|
journal
|
January 2021 |
Cavin1 intrinsically disordered domains are essential for fuzzy electrostatic interactions and caveola formation
|
journal
|
February 2021 |
Overview of the CCP4 suite and current developments.
|
text
|
January 2011 |
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
|
text
|
January 2010 |
Risk of Primary Infection and Reinfection With Respiratory Syncytial Virus
|
journal
|
June 1986 |
Cleavage of the respiratory syncytial virus fusion protein is required for its surface expression: role of furin
|
journal
|
June 2000 |
Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion
|
journal
|
September 2020 |
Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants
|
journal
|
January 2018 |
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants
|
journal
|
May 2017 |
Identification of Linear Heparin-Binding Peptides Derived from Human Respiratory Syncytial Virus Fusion Glycoprotein That Inhibit Infectivity
|
journal
|
October 2006 |
The Core of the Respiratory Syncytial Virus Fusion Protein Is a Trimeric Coiled Coil
|
journal
|
July 2000 |
The Fusion Glycoprotein of Human Respiratory Syncytial Virus Facilitates Virus Attachment and Infectivity via an Interaction with Cellular Heparan Sulfate
|
journal
|
July 2000 |
Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1
|
journal
|
September 2002 |
Respiratory syncytial virus: current and emerging treatment options
|
journal
|
April 2014 |